FOR the first time a gene that plays a role in the development of some non-hereditary forms of breast and ovarian cancer has been identified. The discovery is not likely to lead to new treatments straight away, but it should give doctors a more accurate idea of patients’ chances of survival and help ensure they receive the most appropriate care.
It is known that women who inherit mutated versions of genes called BRCA1 and BRCA2 are more likely to develop breast cancer. But these mutations account for only 5 per cent of all cases. Suspecting a link between hereditary and…
